• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Diabetic foot ulcers - new treatments (suspended)

New treatments for diabetic foot ulcers

Status:	Suspended
Expected date of issue:	TBC
Referral date:	March 2003
Wave:	8
Process:	MTA
Notes: Withdrawn from work prgramme - see below for further information
Topic area: Endocrine, nutritional and metabolic Skin Therapeutic procedures

Project team | Schedule | Stakeholders | Project history | Key documents

 

NICE project team

Executive Lead:	Peter Littlejohns
Technical Lead:	Janet Robertson
Communications manager:	Fraser Woodward
Project manager:	Nina Pinwill
Assessment group:	Health Economics Research Unit & Health Services Research Unit, University of Aberdeen

Top

 

Provisional schedule

Consultation on draft scope by stakeholders:	September 2003
1st appraisal committee meeting:	01 January 2100
2nd appraisal committee meeting:	TBC

Top

 

Consultees and commentators

To be confirmed

Top

 

Project history

Date Update 13 February 2004 Topic withdrawn from work programme. The Institute is in the process of considering the responses to a consultation exercise to define the scope of the appraisal of the clinical and cost effectiveness of new treatments for venous leg ulcers. More information on the progress of the appraisal will be published here as soon as it is available.

Top

 

Key documents

NICE appraisal of new treatments for diabetic foot ulcers 13 February 2004 Health Technology Appraisal - New treatments for diabetic foot ulcers 14 November 2003 2003/009 NICE asked to develop guidance on treating eczema, support programmes for parents dealing with conduct disorder in children, use of statins for heart disease, and when hysterectomy is appropriate 31 March 2003

This page was last updated: 29 November 2011